FCGR2A and autoimmune thrombocytopenic purpura: The unresponsiveness occurring in 10–20% of ITP patients could be due to a destruction of platelets not dependent on FcγR, as proposed for anti-GPIb/IX antibodies [21], a hypothesis that is controversial in clinical practice [22,23].